Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Seizure related 6 homolog (SEZ6) is a type I transmembrane protein highly expressed in the nervous system, critical for neuronal development, synaptic connectivity, and motor coordination[1][3]. It acts as a trafficking factor for kainate receptor subunits GluK2/3, regulating their glycosylation and surface localization in neurons, and is required for the modification of these receptors with specific glycan structures[1]. SEZ6 is a major substrate of the β-secretase enzyme BACE1 in the brain, and changes in SEZ6 processing or function have been implicated in epilepsy, Alzheimer's disease, and other psychiatric or neurodegenerative disorders[1][3][4]. It is characterized by three CUB domains, five SCR domains, and potential roles in neuronal membrane signaling and cell-cell recognition. The soluble ectodomain shed from SEZ6 can be detected in cerebrospinal fluid and may serve as a biomarker for monitoring BACE1 activity in neurological disease research[3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Seizure related 6 homolog (SEZ6).